Qingdao Baheal Medical INC. (301015.SZ)
CNY 26.67
(-0.34%)
CNY 26.67
(-0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.52 Billion | 7.47 Billion | 7.01 Billion | 5.85 Billion | 4.82 Billion | 3.62 Billion |
| Cost of Revenue | 5.34 Billion | 5.46 Billion | 5.31 Billion | 4.42 Billion | 3.51 Billion | 2.47 Billion |
| Gross Profit | 2.18 Billion | 2 Billion | 1.7 Billion | 1.42 Billion | 1.3 Billion | 1.15 Billion |
| Operating Expenses | 1.29 Billion | 1.29 Billion | 1.09 Billion | 1.01 Billion | 972.15 Million | 808.32 Million |
| Selling, General and Administrative Expenses | 1.28 Billion | 1.28 Billion | 1.09 Billion | 1 Billion | 971 Million | 804.12 Million |
| Research and Development Expenses | 11.19 Million | 3.31 Million | - | - | - | - |
| Other Expenses | 3.71 Million | -303.87 Thousand | 2.86 Million | -8.57 Million | -1.14 Million | -4.19 Million |
| Cost and Expenses | 6.63 Billion | 6.76 Billion | 6.4 Billion | 5.44 Billion | 4.48 Billion | 3.28 Billion |
| Operating Income | 888.2 Million | 711.91 Million | 612.65 Million | 411.75 Million | 334.07 Million | 344.8 Million |
| Interest Expense | 64.02 Million | 58.06 Million | 61.06 Million | 62.24 Million | 58.81 Million | 43.14 Million |
| Income Tax Expense | 233.69 Million | 178.7 Million | 150.4 Million | 93.66 Million | 81.51 Million | 82.52 Million |
| Earnings before Tax | 873.57 Million | 652.94 Million | 548.23 Million | 360.24 Million | 281.84 Million | 331.1 Million |
| Net Income | 656.3 Million | 506.59 Million | 421.64 Million | 272.71 Million | 209.87 Million | 258.1 Million |
| Earnings Per Share Basic | 1.25 | 0.96 | 0.80 | 0.52 | 0.40 | 0.49 |
| Earnings Per Share Diluted | 1.23 | 0.96 | 0.80 | 0.52 | 0.40 | 0.49 |
| Weighted Average Shares Outstanding | 525.04 Million | 525.1 Million | 525.1 Million | 525.1 Million | 525.1 Million | 525.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 533.58 Million | 525.1 Million | 525.1 Million | 525.1 Million | 525.1 Million | 525.1 Million |
| Gross Margin | 0.29 | 0.27 | 0.24 | 0.24 | 0.27 | 0.32 |
| EBIT Margin | 0.13 | 0.10 | 0.09 | 0.07 | 0.07 | 0.10 |
| Profit Margin | 0.09 | 0.07 | 0.06 | 0.05 | 0.04 | 0.07 |
| EBITDA | 976.72 Million | 773.44 Million | 665.84 Million | 448.45 Million | 362.66 Million | 397.03 Million |
| Earnings Before Tax Margin | 0.12 | 0.10 | 0.09 | 0.07 | 0.07 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.54 Billion | 1.92 Billion | 1.65 Billion | 7.52 Billion | 2.05 Billion | 1.85 Billion |
| Cost of Revenue | 1.48 Billion | 1.3 Billion | 1.16 Billion | 5.34 Billion | 1.42 Billion | 1.33 Billion |
| Gross Profit | 1.06 Billion | 619.17 Million | 487.15 Million | 2.18 Billion | 629.67 Million | 512.51 Million |
| Operating Expenses | 606.71 Million | 357.83 Million | 268.54 Million | 1.29 Billion | 403.17 Million | 252.95 Million |
| Selling, General and Administrative Expenses | 843.71 Million | 349.44 Million | 267.53 Million | - | 399.24 Million | 256.49 Million |
| Research and Development Expenses | 19.68 Million | 1.01 Million | - | - | - | 2.57 Million |
| Other Expenses | -236.99 Million | -8.38 Million | -1 Million | 3.71 Million | -3.93 Million | 6.1 Million |
| Cost and Expenses | 2.09 Billion | 1.66 Billion | 1.43 Billion | 6.63 Billion | 1.82 Billion | 1.59 Billion |
| Operating Income | 434.41 Million | 261.34 Million | 218.61 Million | 888.2 Million | 226.49 Million | 259.55 Million |
| Interest Expense | 26.2 Million | 18.7 Million | 14.68 Million | 60.68 Million | 15.35 Million | 9.85 Million |
| Income Tax Expense | 108.89 Million | 55.86 Million | 52.57 Million | 233.69 Million | 69.88 Million | 60.76 Million |
| Earnings before Tax | 433.43 Million | 241 Million | 208.65 Million | 854.67 Million | 220 Million | 243.71 Million |
| Net Income | 272.3 Million | 202.69 Million | 165.99 Million | 656.3 Million | 162.15 Million | 191.67 Million |
| Earnings Per Share Basic | 0.52 | 0.39 | 0.32 | - | 0.31 | 0.37 |
| Earnings Per Share Diluted | 0.50 | 0.37 | 0.31 | - | 0.29 | 0.35 |
| Weighted Average Shares Outstanding | 525.61 Million | 525.61 Million | 525.61 Million | 525.13 Million | 525.25 Million | 525.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 544.61 Million | 545.46 Million | 538.24 Million | 546.42 Million | 560.75 Million | 553 Million |
| Gross Margin | 0.42 | 0.32 | 0.29 | 0.29 | 0.31 | 0.28 |
| EBIT Margin | 0.18 | 0.14 | 0.15 | - | 0.12 | 0.15 |
| Profit Margin | 0.11 | 0.11 | 0.10 | 0.09 | 0.08 | 0.10 |
| EBITDA | 459.63 Million | 275.01 Million | 244.28 Million | - | 239.72 Million | 272.78 Million |
| Earnings Before Tax Margin | 0.17 | 0.14 | 0.13 | 0.12 | 0.11 | 0.14 |
VMM
ENDO
RIBT
CENTRUM
UNI
FNFI